<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Sproxil Blog</title>
	<atom:link href="http://www.sproxil.com/blog/?feed=rss2" rel="self" type="application/rss+xml" />
	<link>http://www.sproxil.com/blog</link>
	<description>Empowering consumers with the right tools to beat the $75B fake medication menace</description>
	<lastBuildDate>Fri, 11 May 2012 18:48:52 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>Mangesh Hirve Joins Sproxil&#8217;s Advisory Board</title>
		<link>http://www.sproxil.com/blog/?p=732</link>
		<comments>http://www.sproxil.com/blog/?p=732#comments</comments>
		<pubDate>Fri, 11 May 2012 18:48:42 +0000</pubDate>
		<dc:creator>Meliza</dc:creator>
				<category><![CDATA[Updates]]></category>

		<guid isPermaLink="false">http://www.sproxil.com/blog/?p=732</guid>
		<description><![CDATA[Sproxil is pleased to announce that Mangesh Hirve has joined the Sproxil Advisory Board. Mangesh is a Product Director at an Upstream Exploration and Product Information company. Prior to joining Sproxil&#8217;s Advisory Board, he was the Sproxil India Country Head. Responsible for launching Sproxil&#8217;s global presence in India, Mangesh also was in charge of recruiting [...]]]></description>
		<wfw:commentRss>http://www.sproxil.com/blog/?feed=rss2&#038;p=732</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sproxil, Inc. Teams with IBM to Help Consumers, Industry, in the Fight Against Drug Counterfeiting</title>
		<link>http://www.sproxil.com/blog/?p=725</link>
		<comments>http://www.sproxil.com/blog/?p=725#comments</comments>
		<pubDate>Tue, 01 May 2012 18:17:07 +0000</pubDate>
		<dc:creator>Meliza</dc:creator>
				<category><![CDATA[Updates]]></category>

		<guid isPermaLink="false">http://www.sproxil.com/blog/?p=725</guid>
		<description><![CDATA[New Software Enhances Pharmaceutical Companies&#8217; Ability to Analyze and Visualize Drug Counterfeiting Patterns in Emerging Markets CAMBRIDGE, Mass. and ARMONK, N.Y., May 1, 2012 &#8211; Sproxil is using IBM technology to help the pharmaceutical industry reduce drug counterfeiting and allow consumers to verify the authenticity of prescriptions in seconds with their mobile phones. Through its [...]]]></description>
		<wfw:commentRss>http://www.sproxil.com/blog/?feed=rss2&#038;p=725</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>East Africa losing money to counterfeiters</title>
		<link>http://www.sproxil.com/blog/?p=721</link>
		<comments>http://www.sproxil.com/blog/?p=721#comments</comments>
		<pubDate>Thu, 19 Apr 2012 14:14:47 +0000</pubDate>
		<dc:creator>Meliza</dc:creator>
				<category><![CDATA[Updates]]></category>

		<guid isPermaLink="false">http://www.sproxil.com/blog/?p=721</guid>
		<description><![CDATA[In a recent article, Mr. Omar Issa, CEO of Investment Climate Facility for Africa states that member states of the East African Community last year lost $500 million in taxes as a result of trade in counterfeits. Fake products penetrated into the local markets are not uncommon to local manufacturers, who experience the negative side [...]]]></description>
		<wfw:commentRss>http://www.sproxil.com/blog/?feed=rss2&#038;p=721</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>SAFETY ALERT: Cancer med found in U.S. found to be counterfeit!</title>
		<link>http://www.sproxil.com/blog/?p=714</link>
		<comments>http://www.sproxil.com/blog/?p=714#comments</comments>
		<pubDate>Wed, 04 Apr 2012 13:26:11 +0000</pubDate>
		<dc:creator>Meliza</dc:creator>
				<category><![CDATA[Updates]]></category>

		<guid isPermaLink="false">http://www.sproxil.com/blog/?p=714</guid>
		<description><![CDATA[Via the FDA: &#8220;FDA lab tests have confirmed that a counterfeit version of Roche’s Altuzan 400mg/16ml (bevacizumab),an injectable cancer medication, found in the U.S. contains no active ingredient. Even if the identified drugs were not counterfeit, Altuzan is not approved by FDA for use in the United States (it is an approved drug in Turkey).&#8221; [...]]]></description>
		<wfw:commentRss>http://www.sproxil.com/blog/?feed=rss2&#038;p=714</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Malaria and Me: How Americans are Part of the World of Global Medicine Counterfeiting</title>
		<link>http://www.sproxil.com/blog/?p=712</link>
		<comments>http://www.sproxil.com/blog/?p=712#comments</comments>
		<pubDate>Tue, 03 Apr 2012 17:19:50 +0000</pubDate>
		<dc:creator>Meliza</dc:creator>
				<category><![CDATA[Updates]]></category>

		<guid isPermaLink="false">http://www.sproxil.com/blog/?p=712</guid>
		<description><![CDATA[Guest-blogpost by Tom Kubic President and CEO of the Pharmaceutical Security Institute A key benefit of globalization is that lifesaving medications can be readily transferred from anywhere in the world to countries like Ghana, Kenya, and South Africa. Unfortunately, globalization has also brought criminal organizations that take advantage of the need for these medications. Criminals [...]]]></description>
		<wfw:commentRss>http://www.sproxil.com/blog/?feed=rss2&#038;p=712</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sproxil CEO Ashifi Gogo Sits at Panel at CGI U 2012</title>
		<link>http://www.sproxil.com/blog/?p=708</link>
		<comments>http://www.sproxil.com/blog/?p=708#comments</comments>
		<pubDate>Mon, 02 Apr 2012 13:28:40 +0000</pubDate>
		<dc:creator>Meliza</dc:creator>
				<category><![CDATA[Updates]]></category>

		<guid isPermaLink="false">http://www.sproxil.com/blog/?p=708</guid>
		<description><![CDATA[The Clinton Global Initiative (CGI), established in 2005 by former U.S. President Bill Clinton, is an effort to bring together a community of global leaders who seek to forge solutions to the world&#8217;s most pressing challenges. CGI then formed CGI University (CGI U) in 2007 to engage the next generation of leaders on college campuses [...]]]></description>
		<wfw:commentRss>http://www.sproxil.com/blog/?feed=rss2&#038;p=708</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Congressional Briefing on Counterfeit Drugs on March 15th, Noon, Washington D.C.</title>
		<link>http://www.sproxil.com/blog/?p=704</link>
		<comments>http://www.sproxil.com/blog/?p=704#comments</comments>
		<pubDate>Fri, 09 Mar 2012 15:28:55 +0000</pubDate>
		<dc:creator>Meliza</dc:creator>
				<category><![CDATA[Updates]]></category>

		<guid isPermaLink="false">http://www.sproxil.com/blog/?p=704</guid>
		<description><![CDATA[Learn about the latest impacts that counterfeit drugs have made upon Americans at the Partnership for Safe Medicine’s Congressional Briefing entitled “Moving Beyond the Avastin Incident: The Continued Impact of Counterfeit Drugs in the United States” on March 15, 2012, NOON, Capitol Visitor Center, Room HVC-201. Last month, the U.S. Food and Drug Administration (FDA) [...]]]></description>
		<wfw:commentRss>http://www.sproxil.com/blog/?feed=rss2&#038;p=704</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The LEADERs Guide for HealthCare Pros</title>
		<link>http://www.sproxil.com/blog/?p=702</link>
		<comments>http://www.sproxil.com/blog/?p=702#comments</comments>
		<pubDate>Mon, 05 Mar 2012 21:38:19 +0000</pubDate>
		<dc:creator>Meliza</dc:creator>
				<category><![CDATA[Updates]]></category>

		<guid isPermaLink="false">http://www.sproxil.com/blog/?p=702</guid>
		<description><![CDATA[Usually when healthcare professionals think about patients getting counterfeit drugs, they assume the patient ordered a drug from a foreign website pharmacy that&#8217;s nothing more than an online front for counterfeiters. However in early February the US Food and Drug Administration announced that it had discovered an unlicensed supplier selling fake Bevacizumab injectables (under the [...]]]></description>
		<wfw:commentRss>http://www.sproxil.com/blog/?feed=rss2&#038;p=702</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sproxil&#8217;s MPA Product Verification Solution on IBM&#8217;s Global Solutions Directory</title>
		<link>http://www.sproxil.com/blog/?p=699</link>
		<comments>http://www.sproxil.com/blog/?p=699#comments</comments>
		<pubDate>Wed, 29 Feb 2012 14:54:12 +0000</pubDate>
		<dc:creator>Meliza</dc:creator>
				<category><![CDATA[Updates]]></category>

		<guid isPermaLink="false">http://www.sproxil.com/blog/?p=699</guid>
		<description><![CDATA[We are pleased to announce that our Mobile Product Authentication (MPA) Solution has been approved and is now on IBM&#8217;s Global Solutions Directory, an online directory containing thousands of applications, tools and services from IBM and IBM Business Partners. As a Business Partner with IBM, Sproxil has been equipped with access to software and resources [...]]]></description>
		<wfw:commentRss>http://www.sproxil.com/blog/?feed=rss2&#038;p=699</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BCtA publishes a case study on Sproxil</title>
		<link>http://www.sproxil.com/blog/?p=697</link>
		<comments>http://www.sproxil.com/blog/?p=697#comments</comments>
		<pubDate>Mon, 27 Feb 2012 16:54:29 +0000</pubDate>
		<dc:creator>Meliza</dc:creator>
				<category><![CDATA[Updates]]></category>

		<guid isPermaLink="false">http://www.sproxil.com/blog/?p=697</guid>
		<description><![CDATA[We are happy to announce that the Business Call to Action (BCtA) has recently published a case study on Sproxil. Our company joined BCtA with a commitment to mobilize US$4 million to expand efforts to empower patients and consumers in the fight against counterfeit medication in India and Kenya. To learn more about Sproxil&#8217;s efforts [...]]]></description>
		<wfw:commentRss>http://www.sproxil.com/blog/?feed=rss2&#038;p=697</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

